Allegra-D is kept behind the pharmacy counter because it contains pseudoephedrine, a nasal decongestant that can be chemically converted into methamphetamine. Federal law has required all products containing pseudoephedrine to be sold from behind the counter since 2006. Regular Allegra, which contains only the antihistamine fexofenadine, sits on the shelf like any other allergy pill. The “D” version adds pseudoephedrine as a decongestant, and that single ingredient triggers the restriction.
The Ingredient That Changes Everything
Allegra-D 24 Hour contains two active ingredients: 180 mg of fexofenadine (the same antihistamine in regular Allegra) and 240 mg of pseudoephedrine (a decongestant that shrinks swollen nasal passages). Fexofenadine blocks histamine to reduce sneezing, itching, and runny nose. Pseudoephedrine constricts blood vessels in the nasal lining, which is what actually opens up a stuffy nose. It’s effective, but its chemical structure is close enough to methamphetamine that it can be used as a starting material to manufacture the drug.
Multiple methods exist for converting pseudoephedrine into methamphetamine, and they don’t require sophisticated lab equipment. The National Drug Intelligence Center has documented several common approaches, all of which use pseudoephedrine or its close relative ephedrine as the principal ingredient. These methods can yield high-quality methamphetamine in quantities ranging from ounces to multiple pounds. That accessibility is what prompted Congress to act.
The Law Behind the Counter
The Combat Methamphetamine Epidemic Act of 2005, which took effect in 2006, created the behind-the-counter requirement for all products containing pseudoephedrine, ephedrine, or phenylpropanolamine. This applies to every brand, not just Allegra-D. Sudafed, Claritin-D, Zyrtec-D, and store-brand equivalents all follow the same rules.
The law sets specific purchase limits. You can buy no more than 3.6 grams of pseudoephedrine base per day and no more than 9 grams in a 30-day period. To put that in practical terms, a box of Allegra-D 24 Hour with fifteen 240 mg tablets contains 3.6 grams of pseudoephedrine, so one box hits the daily limit exactly. You could buy roughly two and a half boxes in a month before reaching the 30-day cap.
What Happens When You Buy It
The process is straightforward but more involved than grabbing a box off the shelf. You need to ask at the pharmacy counter, show a government-issued photo ID, and sign a logbook or electronic record. Many states now use a real-time electronic tracking system called NPLEx (National Precursor Log Exchange) that checks your purchase history against the federal limits before the sale goes through. If you’ve already bought your allotment for the month, the system will block the transaction on the spot.
You do not need a prescription in most states. Allegra-D remains an over-the-counter product. “Behind the counter” is a distinct category: no prescription required, but you can’t browse for it on the shelf or buy it through a self-checkout lane. A few states, including Oregon and Mississippi, have gone further and made pseudoephedrine prescription-only, so the rules depend on where you live.
Why Not Just Use a Different Decongestant?
For years, drug manufacturers reformulated their “D” products with phenylephrine, a decongestant that could stay on open shelves because it has no methamphetamine potential. The problem: phenylephrine taken by mouth barely works. Only about 38% of an oral phenylephrine dose reaches the bloodstream, compared to roughly 90% of a pseudoephedrine dose. Multiple clinical studies found that standard oral doses of phenylephrine performed no better than a placebo at reducing nasal congestion.
In September 2023, an FDA advisory committee formally concluded that oral phenylephrine at its approved dose is not effective as a nasal decongestant. The committee also considered whether a higher dose might work but found no clinical evidence supporting a safe and effective alternative dose. This left pseudoephedrine as the only proven oral decongestant on the market, which makes the behind-the-counter requirement more relevant than ever for allergy sufferers who need real congestion relief.
Other options that do work include nasal spray decongestants, intranasal corticosteroid sprays, and certain intranasal antihistamines. But for people who prefer a pill, pseudoephedrine remains the gold standard, and the pharmacy counter remains the only place to get it.
Regular Allegra vs. Allegra-D
If your main symptoms are sneezing, itching, and a runny nose, regular Allegra handles those without any purchasing restrictions. The fexofenadine in it is a straightforward antihistamine with no abuse potential or regulatory concerns. You’ll find it on the shelf at any pharmacy or grocery store.
Allegra-D makes sense when nasal congestion is part of the picture. Antihistamines alone don’t do much for a blocked nose, because congestion is driven more by swollen blood vessels than by histamine. Adding pseudoephedrine targets that swelling directly. The tradeoff is the extra step at the pharmacy counter, the ID requirement, and the purchase limits. For most people, the process adds about five minutes to the transaction. It’s a minor inconvenience rooted in a serious public health problem, and it’s unlikely to change as long as pseudoephedrine remains the primary precursor for illicit methamphetamine production.